Speakers

Co-Founder and CSO, CellVec Pte Ltd

CTO, Masthercell

Professor of Biomedical Engineering & Orthopaedic Surgery / Mary Muilenberg Stamp Professor of Orthopaedic Research / Director of Basic and Translational Research in Orthopaedic Surgery, University of Virginia

Global Head of Cell Therapy, Hemacare

Manager of Regulatory Affairs, Brammer Bio part of Thermo Fisher Scientific

Director for the Program in Translational Immunology and Research Director at the Institute of Molecular and Cell Biology (IMCB); | CSO, Agency for Science, Technology and Research (A*STAR) | Tessa Therapeutics

Assistant Professor, Diabetes Research Institute, Cell Transplant Center and Department of Orthopedics - UHealth Sport Medicine Institute, University of Miami Miller School of Medicine

Chief Scientific Officer, Northern Therapeutics Inc.

Senior Product Manager Lentiviral Vectors, Miltenyi Biotec GmbH

Founder and CEO, Dark Horse Consulting

Founder & Managing Director, August

Consultant Paediatric Surgeon / Reader & Head of Stem Cells & Regenerative Medicine, Great Ormond Street / UCL

Director of Product Management, Thermo Fisher Scientific

VP New Technology/Chief Scientific Officer, AgeX Therapeutics/SENS Research Foundation

Business Director, ICCBBA

Ph.D., Evolvis Consulting

Senior Consultant Cell and Gene Therapy, ERA Consulting

Director, Center for Antibody Therapeutics, University of Pittsburgh, Department of Medicine

Director of the Biorepository/Director of the Experimental Pathology program, Mount Sinai

CSO & General Manager, Lentigen Technology, Inc. a Miltenyi Biotec company